Systemic inflammation is associated with increased risk in the development of atherosclerosis as well as other cardiovascular diseases (CVD). Recent trials have thus investigated whether immunotherapies may decrease the risk of CVD (Ridker et al. 2017; Tardif et al. 2019; Liberale et al. 2021). However, there remains a dearth of knowledge regarding which inflammatory proteins may play an aetiological and/or mediating role, and thereby may be potential therapeutic targets in the prevention of CVD. We seek to investigate the associations of the 92 Olink inflammatory proteins, measured in approximately 3000 mothers, 3000 children at age 9 and another 3000 children at age 24, with changes in carotid intima-media thickness (cIMT), pulse wave velocity (PWV) and blood pressures. We will also perform the analyses on the inflammatory biomarkers Glyoprotein Acetyls (GlycA) and C-reactive protein (CRP), as well as IL-6 measured in the 9-year-olds via clinical chemistry, since IL-6 is the only protein measured by Olink that has been measured previously in ALSPAC to be used as a validation.